DOCSLIB.ORG

Govea-Dissertationdoctoral

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Govea-Dissertationdoctoral Copyright by Rosann Mae Govea 2015 The Dissertation Committee for Rosann Mae Govea Certifies that this is the approved version of the following dissertation: Group III mGluR8 negatively modulates TRP channels Committee: Susan M Carlton, Ph.D., Mentor Darren Boehning, Ph.D. Hongzhen Hu, Ph.D. Volker Neugebauer, M.D., Ph.D. Shao-Jun Tang, Ph.D. _______________________________ Dean, Graduate School of Biomedical Sciences Group III mGluR8 negatively modulates TRP Channels by Rosann Mae Govea, B.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas Medical Branch in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas Medical Branch March, 2015 Dedication To my best friend and close confidant Chris Sommerfeld. To my parents Pete and Lucy Govea and my sisters: Roxann, Lucinda, and Mercedes. Thank you for all of your support and encouragement. To my mentor, Dr. Susan Carlton, you are an inspiration. To my very close friend Audrie Medina … our escapes and fantasies of being farmers. Acknowledgements Chris, thank you for all of your love and support throughout the years. I appreciated the times you would stay up late to keep me company while I was working. I’d like to thank my family and close friends. First, my parents Pete and Lucy thank you for your encouragement and support. Y’all have always been supportive of all of us. My sisters: Roxann, Lucinda and Mercedes. Thank you for always being there. The months leading up to this point have been rough, and I wouldn’t have been able to come this far without a strong support group. Shengtai, Zhixia, Greg, Junhui, and Dale, thank you for having patience with me as I learned techniques. I have gained a lot of knowledge from all of you. I felt as if I was part of the lab family as soon as I joined the lab. Alyssa, my labmate, I was so glad when you joined the lab. I enjoyed all of our discussions, I’ll miss them. Thanks for being a listening ear when I needed it. Dr. Carlton, first, thank you for allowing me to join your lab as part of the PREP program. I have come so far from that first day. Thank you for all of our encouragement and support throughout the years. Thank you for your understanding and patience, especially in the months leading up to now. Audrie Medina, I am so fortunate to be your friend. We hit it off from the first time we met. I will miss our coffee break escapes. Thanks for all of your support throughout the years. Dr. Niesel, thank you for your continual support and words of encouragement. iv Sally, my therapist, you’ve helped me so much. The months leading up to now have been rough to say the least. I would not have made it this far without your help. Lastly, I would like to acknowledge my committee members Dr. Darren Boehning, Dr. Hongzhen Hu, Dr. Volker Neugebauer, and Dr. Shao-Jun Tang. Thank you all for serving on my dissertation committee. I appreciate all of the advice and support. v Group III mGluR8 negatively modulates TRPA1 activity Publication No._____________ Rosann Mae Govea, Ph.D. The University of Texas Medical Branch, 2015 Supervisor: Susan M. Carlton, Ph.D. Several lines of evidence indicate group III metabotropic glutamate receptors (mGluRs) have systemic anti-hyperalgesic effects. We hypothesized this could occur through modulation of TRP channels on nociceptors. The following studies used a multifaceted approach to examine the interaction between group III mGluRs (mGluR8) and two TRP channels: TRPV1 and TRPA1. In the first study, we examined the interaction between group III mGluRs and TRPV1. Anatomical studies demonstrated that group III mGluR8 is expressed on cutaneous axons and is co-localized with TRPV1 in the dorsal root ganglia (DRG). In behavior studies, peripheral activation of group III mGluRs had no effect on paw withdrawal latency (PWL) to heat in naïve rats. However, local peripheral activation of group III mGluRs significantly attenuated capsaicin (CAP, TRPV1 agonist)-induced lifting/licking and reduced flinching behavior. Finally peripheral group III mGluR activation reversed forskolin (FSK)-induced heat sensitivity, suggesting that group III could modulate TRPV1 by down-regulating cAMP-PKA activity. In the second part of the study, we examined the interaction between group III mGluR8 and TRPA1. Ca2+ imaging studies demonstrated co-localization and functional vi coupling of TRPA1 and mGluR8, since DCPG (mGluR8 agonist) significantly reduced the number of mustard oil (MO, TRPA1 agonist) responsive cells. Behavioral studies demonstrated that peripheral DCPG reversed the MO-induced decrease in PWT. At the single fiber level, DCPG significantly attenuated MO-induced nociceptor activity and reversed the MO-induced decrease in mechanical threshold. Furthermore, DCPG significantly reduced the number of MO-induced mechanically sensitive fibers. Inhibition of PKA using RpCAMPS significantly reduced MO-induced calcium mobilization and there was a trend to reduce the number of MO-responsive cells. Taken together, these results show that group III mGluRs can negatively modulate TRPV1 and TRPA1 activity. Furthermore, it is likely that this modulation occurs at the level of the cAMP/PKA pathway. Additionally, these studies demonstrate that group III agonists may be effective in treatment of mechanical allodynia which can develop as a result of inflammation, nerve injury, chemotherapy or other disease states. vii TABLE OF CONTENTS List of Tables .............................................................................................................xii List of Figures ............................................................................................................xiii List of Abbreviations .................................................................................................xiv CHAPTER 1: EXPANDED INTRODUCTION ..................................................................17 Pain Pathways ............................................................................................................18 Spinothalamic tract ...........................................................................................18 Transient Receptor Potential (TRP) ion Channels and Pain ......................................19 TRP channel discovery .....................................................................................19 TRPV1 ..............................................................................................................20 TRPV1: more than a Pain Receptor ..................................................................21 TRPA1 ..............................................................................................................22 TRPA1: more than a pain receptor ...................................................................23 Metabotropic Glutamate Receptors (mGluRs) ..........................................................24 Groups I, II, III ..................................................................................................24 mGluR8 localization .........................................................................................25 Group III mGluRs (mGluR8 and pain) .............................................................25 mGluR8: more than a pain modulator ..............................................................26 CHAPTER 2: GROUP III MGLURS NEGATIVELY MODULATE TRPV1 ACTIVITY .....28 Introduction ................................................................................................................28 Methods......................................................................................................................30 Animal Use and Care ........................................................................................30 Immunostaining of the digital nerve at the electron microscopic level ............30 Immunostaining the dorsal root ganglia at the light microscopic level ............31 Tissue Collection .....................................................................................31 Immunohistochemistry ............................................................................32 Cresyl Violet ............................................................................................32 viii Analysis....................................................................................................33 Behavior ............................................................................................................33 Drug Preparations ....................................................................................33 Drug Injections.........................................................................................34 Habituation for behavioral testing ...........................................................34 Testing for thermal and CAP-induced behaviors .....................................35 Data Analysis ...........................................................................................35 Results ........................................................................................................................36 mGluR8-labeled digital axons ..........................................................................36 mGluR8 and TRPV1 are co-localized on rat DRG cells ..................................37 Group III mGluR agonist L-AP-4 attenuates CAP-induced nociceptive behaviors ..................................................................................................40 Group III mGluR activation modulates
Load more

Recommended publications
  • Original Article Effect of GABA on Blood Pressure and Blood Dynamics of Anesthetic Rats
    Int J Clin Exp Med 2015;8(8):14296-14302 www.ijcem.com /ISSN:1940-5901/IJCEM0008622 Original Article Effect of GABA on blood pressure and blood dynamics of anesthetic rats Pengju Ma1, Ting Li2, Fanceng Ji3, Haibo Wang4, Juntao Pang4 1Department of Anesthesiogy, Anqiu People’s Hospital, Anqiu 262100, China; 2Delivery Room, People’s Hospital of Anqiu, Anqiu 262100, China; 3Department of Anesthesiogy, Weifang People’s Hospital, Weifang 261041, China; 4Department of Critical Care Medicine of Weifang People’s Hospital, Weifang 261041, China Received March 31, 2015; Accepted August 13, 2015; Epub August 15, 2015; Published August 30, 2015 Abstract: Background: This study aimed to investigate GABA effects on blood pressure and blood dynamics of an- esthetic rats by observing spontaneously hypertensive rats under both anesthesia and waking state. Materials and methods: 72 male waking Wistar-Kyokos (WKY) rats and 72 male anesthetized spontaneously hypertensive (SHR) rats were randomly divided into control group and experimental group (N = 36 each). Rats were further divided into three subgroups (N = 12 each), which received 15 μmol GABA, 35 nmol muscimol, or 4 nmol dicentrine into uni- lateral paraventricular nucleus, respectively. Rats in the control group (WKY1) and experimental group (SHR1) were compared for the GABA effect on blood pressure (MAP), heart rate (HR), and arterial baroreceptor reflex function (BRS) changes under waking state. Anesthetic WKY rats (WKY2) and spontaneously hypertensive rats (SHR2) were compared for the GABA effect on those abovementioned indexes. Abdominal aorta mean arterial pressure, heart rate, and arterial baroreceptor reflex function changes were compared in all rats. Results: MAP, HR, and BRS were slightly lower in the rats under anesthetic state than in waking state before treatment (P < 0.05); they did not show significant changes between anesthetic and waking state, however, after treatment (P > 0.05).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,980,319 B2 Park Et Al
    US00898O319B2 (12) United States Patent (10) Patent No.: US 8,980,319 B2 Park et al. (45) Date of Patent: *Mar. 17, 2015 (54) METHODS OF PRODUCING STABILIZED A613 L/445 (2006.01) SOLID DOSAGE PHARMACEUTICAL A613 L/47 (2006.01) COMPOSITIONS CONTAINING A6II 45/06 (2006.01) MORPHINANS A63/67 (2006.01) (52) U.S. Cl. (71) Applicant: Mallinckrodt LLC, Hazelwood, MO CPC ............. A6 IK3I/485 (2013.01); A61 K9/1652 (US) (2013.01); A61 K9/2031 (2013.01); A61 K 9/2081 (2013.01); A61 K9/2086 (2013.01); (72) Inventors: Jae Han Park, Olivette, MO (US); A6IK9/2095 (2013.01); A61 K9/5042 Tiffani Eisenhauer, Columbia, IL (US); (2013.01); A61 K3I/4355 (2013.01); A61 K Spainty,S.Isna Gupta, F11llsborough, 31/4375A6 (2013.01); IK3I/445 gets (2013.01); it' A6 (2013.01); IK3I/47 Stephen Overholt, Middlesex, NJ (US) (2013.01); A61K 45/06 (2013.01); A61 K 9/2013 (2013.01); A61 K9/209 (2013.01); (73) Assignee: Mallinckrodt LLC, Hazelwood, MO A6 IK3I/167 (2013.01) (US) USPC ........... 424/472: 424/465; 424/468; 424/490; c - r - 514/282; 514/289 (*) Notice: Subject to any disclaimer, the term of this (58) Field of Classification Search patent is extended or adjusted under 35 N U.S.C. 154(b)b) by 0 daysyS. Seeone application file for complete search history. This patent is Subject to a terminal dis claimer. (56) References Cited (21) Appl. No.: 14/092.375 U.S. PATENT DOCUMENTS (22) Filed: Nov. 27, 2013 2008, 0026052 A1 ck 1/2008 Schoenhard .................
    [Show full text]
  • An in Silico Study of the Ligand Binding to Human Cytochrome P450 2D6
    AN IN SILICO STUDY OF THE LIGAND BINDING TO HUMAN CYTOCHROME P450 2D6 Sui-Lin Mo (Doctor of Philosophy) Discipline of Chinese Medicine School of Health Sciences RMIT University, Victoria, Australia January 2011 i Declaration I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at RMIT university or any other educational institution, except where due acknowledgment is made in the thesis. Any contribution made to the research by others, with whom I have worked at RMIT university or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project‘s design and conception or in style, presentation and linguistic expression is acknowledged. PhD Candidate: Sui-Lin Mo Date: January 2011 ii Acknowledgements I would like to take this opportunity to express my gratitude to my supervisor, Professor Shu-Feng Zhou, for his excellent supervision. I thank him for his kindness, encouragement, patience, enthusiasm, ideas, and comments and for the opportunity that he has given me. I thank my co-supervisor, A/Prof. Chun-Guang Li, for his valuable support, suggestions, comments, which have contributed towards the success of this thesis. I express my great respect to Prof. Min Huang, Dean of School of Pharmaceutical Sciences at Sun Yat-sen University in P.R.China, for his valuable support.
    [Show full text]
  • Dicentrine Production from a Hairy Roots Culture of Stephania Suberosa
    Dicentrine Production from a Hairy Roots Culture of Stephania suberosa Waraporn Putalun*, Gorawit Yusakul, and Denpong Patanasethanont Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand. Fax: +66-43-2 02-3 79. E-mail: [email protected] * Author for correspondence and reprint requests Z. Naturforsch. 64 c, 692 – 696 (2009); received June 8/July 2, 2009 A hairy roots culture of Stephania suberosa was established using Agrobacterium rhizo- genes ATCC15834. The production of dicentrine was found to be (8.92 ± 0.07) mg/g dry wt on day 35 of culture. Effects of sucrose content, tyrosine, and medium strength on growth and dicentrine production of S. suberosa were investigated. 6% (w/v) sucrose was an op- timum content for the growth and dicentrine accumulation in S. suberosa hairy roots. The utilization of a precursor from tyrosine feeding enhanced the dicentrine production. The medium with 1.0 mM of tyrosine had the highest effect on dicentrine accumulation in hairy roots at day 40 of culture [(14.73 ± 0.47) mg/g dry wt]. In addition, ¼ Murashige and Skoog medium was suitable for biomass and dicentrine production in hairy roots. This culture sys- tem has a potential to produce dicentrine from hairy roots of S. suberosa. Key words: Dicentrine, Hairy Roots, Stephania suberosa Introduction achieved in S. suberosa tuberous roots (Patra et al., 1986; Sriprang et al., 2006). Therefore, hairy Stephania suberosa Forman (Menispermaceae) roots cultures of S. suberosa are necessary for the is a medicinal plant which has been used in Thai production of biological compounds. It is known traditional medicine for the treatment of hyper- that many factors could affect the secondary me- tension.
    [Show full text]
  • Poisonous Properties of Bikukulla Cuculla- Ria (Dutchman's-Breeches) and B
    POISONOUS PROPERTIES OF BIKUKULLA CUCULLA- RIA (DUTCHMAN'S-BREECHES) AND B. CANADENSIS (SQUIRREL-CORN)1 By O. F. BivACK, Chemical Biologist, W. W. EGGLESTON, Assistant Botanist, and J. W. K^LLY, Chemical Laboratorian, Office of Drug, Poisonous, and Oil Plant Investigations, Bureau of Plant Industry, United States Department of Agriculture, and H. C. TURNER, Assistant Animal Husbandman, Virginia Agricultural Experiment Station INTRODUCTION Since the time of the early settlements in the mountains of Virginia frequent fatal cases of poisoning have occurred among cattle grazing in the mountain pastures in early spring. It has long been believed that certain early spring plants popularly known as <<staggerweeds,, have been the cause of these fatalities, since these plants are among the first to appear in the pastures and are often eaten by cattle when other forage is not abundant. Suspicion has chiefly centered upon the plants com- monly called larkspur (Delphinium tricorne Michx.), dutchman's-breeches (Bikukulla cucullaria (L.) Millsp.)> squirrel-corn (B. canadensis (Goldie) Millsp.), and wild bleeding heart (B. eximia (Ker) Millsp.). In the literature relating to poisonous plants the toxic character of D. tricorne has long been recognized, but the American species of Bikukulla appear to have received comparatively little attention from chemists and prac- tically none from toxicologists. The probable poisonous character of species of Bikukulla was first brought to the attention of the Department of Agriculture in June, 1920, by Prof. H. S. Stahl, of the Virginia Polytechnic Institute. He sub- mitted specimens of "little staggerweed," later identified as Bikukulla cucullaria y with the statement that this plant was believed to be respon- sible for the recent death of a number of cattle in the mountain pastures of Bland County, Va.
    [Show full text]
  • Mother Root of Aconitum Carmichaelii Debeaux Exerts
    Wang et al. J Transl Med (2015) 13:284 DOI 10.1186/s12967-015-0636-4 RESEARCH Open Access Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complete Freund’s Adjuvant‑induced mice: roles of dynorphin/kappa‑opioid system and transient receptor potential vanilloid type‑1 ion channel Chao Wang1†, Danni Sun1†, Chunfang Liu1*, Chunyan Zhu1, Xianghong Jing2, Shuping Chen2, Cuiling Liu1, Kai Zhi1, Tengfei Xu3,4, Hui Wang1, Junling Liu2, Ying Xu1, Zhiqiang Liu3 and Na Lin1* Abstract Background: Processed Chuanwu (PCW), the mother root of Aconitum carmichaelii Debeaux, has been widely used as a classic Traditional Chinese Medicine for pain relieve for over two millennia clinically. However, its action on chronic inflammatory pain has not been clarified. Here, we investigated the antinociceptive effect of PCW in complete freund’s adjuvant (CFA)-induced mice and its possible mechanisms associated with opioid system and TRPV1 ion channel. Methods: Male ICR mice were intraplantarly injected with CFA. PCW (0.34, 0.68 and 1.35 g/kg) was orally given to mice once a day for 7 days. Von frey hairs and plantar test were assessed to evaluate the antinociceptive effect of PCW. To investigate the participation of dynorphin/opioid system in PCW antinociception, subtype-specific opioid receptor antagonists or anti-dynorphin A antiserum were used. To eliminate other central mechanisms that contribute to PCW antinociception, hot plate (50 °C) test were performed. Further, involvements of TRPV1 in PCW antinociception were / / evaluated in CFA-induced TRPV1− − and TRPV1+ + C57BL/6 male mice, and in capsaicin-induced nociception ICR naive mice pretreated with nor-binaltorphimine (nor-BNI).
    [Show full text]
  • JORGE LUIZ DALLAZEN.Pdf
    UNIVERSIDADE FEDERAL DO PARANÁ JORGE LUIZ DALLAZEN AVALIAÇÃO DO EFEITO DA ADMINISTRAÇÃO LOCAL DE ALQUILAMIDAS EM DIFERENTES MODELOS DE DOR EM CAMUNDONGOS CURITIBA 2019 1 JORGE LUIZ DALLAZEN AVALIAÇÃO DO EFEITO DA ADMINISTRAÇÃO LOCAL DE ALQUILAMIDAS EM DIFERENTES MODELOS DE DOR EM CAMUNDONGOS Dissertação apresentada ao Programa de Pós-Graduação em Farmacologia do Departamento de Farmacologia, Setor de Ciências Biológicas da Universidade Federal do Paraná como requisito parcial para a obtenção do título de Mestre em Farmacologia. Orientadora: Profª Drª Maria Fernanda de Paula Werner CURITIBA 2019 ! "#$%$&'( )* + ,) - .0 2 .0 3 2 # + ,) ) ! * 45'$ '65 78 9 8 : .0 ( % * %; .0 ' + 4 < 7.0 & 6 7% 7 = >? == :* === %; .0 44 ( A'A56B A'CC 3 4 AGRADECIMENTOS Agradeço aos meus pais, Márcia e Edenilson, pelo apoio, incentivo, educação, amor e paciência. Muito obrigado por terem me proporcionado as melhores condições e trilhado meu caminho para que eu chegasse onde estou, mesmo sem entenderem muito bem o que faço! Agradeço à minha namorada, Gabriela, sobretudo pelo amor e carinho compartilhado durante todos esses nossos anos juntos. Seu apoio e compreensão foram fundamentais, e hoje, sem dúvidas, você é a Engenheira Civil que mais entende de farmacologia. À minha orientadora, Maria Fernanda, que em 2014 me aceitou em seu laboratório. Desde então foram anos de ensinamentos e aprendizados sobre ciência, ética e amor pela pesquisa. Uma mãe que a farmacologia me deu. Serei sempre muito grato e orgulhoso por ter trabalhado ao seu lado. À minha amiga Dani, por ter sido uma inspiração, por ter dividido horas e horas de café, besteiras e ranço. Obrigado por ter aguentado minhas piadas ruins e rido delas.
    [Show full text]
  • Acetanilid, Effects Of, on Growth and Blood Morphology of Rats 34 Growth
    INDEX Acetanilid, Effects of, on growth and blood morphology of rats . 34 -, Growth and blood morphology of rats receiving sodium bromide, caffeine and combinations with 43 Acetyicholine, Effect of acid on guinea pig ileum contracted by histamine and 253 Acid, Effect of, on guinea pig ileum contracted by acetylcholine and histamine 253 Alcohol injected intravenously : Further observations on effect of habituation on rate of metabolism 388 - metabolism, Effect of dinitrophenol on rate of 67 Alkylaryl thioureas, unsymmetrical, Relative hypnotic effects of some aryl ajid 19 Amidine and guanidine derivatives, Toxicity and glycaemic properties of number of 81 D’Amour, Fred E., and Gustavson, R. G. Biologic assay of “International Standard” estrin and of certain commercial preparations 472 Anaphylactic shock, canine, R#{244}le of histamine in 419 Anesthesia, morphine-sodium isoamylethylbarbiturate (sodium amytal) and ether, Antagonism between ephedrine sulphate and sodium isoamylethyl- barbiturate after intracisternal injection during 464 -‘ spinal, On duration of, in rabbit 264 Anaesthetic actions, Local, of certain pyrazoline and quinoline compounds. 199 - effects of some furan derivatives 394 - Threshold, and lethal concentrations of certain spinal anesthetics in rabbit 221 Anil and styryl quinoline compounds free from metals or metalloids, Chemo- therapeutic action on Sp. minus in mice by certain 56 Antrum, pyloric sphincter and duodenum, Effect of morphine sulphate and of dihydromorphinone hydrochloride upon, in non-anesthetized dogs 170 Argy, William P., Linegar, Charles R., and Dille, James M. Studies on barbiturates. XV. Excretion of barbital in normal and nephropathic subjects 258 Aryl and unsymmetrical alkylaryl thioureas, Relative hypnotic effects of some 19 Barbital, Excretion of, in normal and nephropathic subjects 258 Barbiturates, Addiction and tolerance to 245 -, On cause of delayed death in rat by isopropyl betabromallyl barbituric acid (nostal) and some related 289 -, Studies on.
    [Show full text]
  • Alkaloids – Secrets of Life
    ALKALOIDS – SECRETS OF LIFE ALKALOID CHEMISTRY, BIOLOGICAL SIGNIFICANCE, APPLICATIONS AND ECOLOGICAL ROLE This page intentionally left blank ALKALOIDS – SECRETS OF LIFE ALKALOID CHEMISTRY, BIOLOGICAL SIGNIFICANCE, APPLICATIONS AND ECOLOGICAL ROLE Tadeusz Aniszewski Associate Professor in Applied Botany Senior Lecturer Research and Teaching Laboratory of Applied Botany Faculty of Biosciences University of Joensuu Joensuu Finland Amsterdam • Boston • Heidelberg • London • New York • Oxford • Paris San Diego • San Francisco • Singapore • Sydney • Tokyo Elsevier Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK First edition 2007 Copyright © 2007 Elsevier B.V. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation
    [Show full text]
  • SIMOES, ROLI RODRIGUES.Pdf (3.040Mb)
    1 MINISTÉRIO DA EDUCAÇÃO UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA Potencial terapêutico do extrato metanólico de Condalia buxifolia Reissek no controle da dor aguda: estudo do mecanismo de ação TESE DE DOUTORADO Róli Rodrigues Simões Santa Maria, RS, Brasil 2015 2 Potencial terapêutico do extrato metanólico de Condalia buxifolia Reissek no controle da dor aguda: estudo do mecanismo de ação por Róli Rodrigues Simões Tese apresentada ao Curso de Doutorado do Programa de Pós-Graduação em Farmacologia, Área de Concentração Neuropsicofarmacologia e Imunofarmacologia, da Universidade Federal de Santa Maria (UFSM, RS), como requisito parcial para a obtenção do grau de Doutor em Farmacologia. Orientador: Prof. Dr. Adair Roberto Soares dos Santos Santa Maria 2015 Ficha catalográfica elaborada através do Programa de Geração Automática da Biblioteca Central da UFSM, com os dados fornecidos pelo(a) autor(a). Rodrigues Simões, Róli Potencial terapêutico do extrato metanólico de Condalia buxifolia Reissek no controle da dor aguda: estudo do mecanismo de ação / Róli Rodrigues Simões.-2015. 172 p.; 30cm Orientador: Adair Roberto Soares dos Santos Tese (doutorado) - Universidade Federal de Santa Maria, Centro de Ciências da Saúde, Programa de Pós- Graduação em Farmacologia, RS, 2015 1. Condalia buxifolia 2. camundongos 3. opióide 4. TRPV1 5. PKA I. Soares dos Santos, Adair Roberto II. Título. 3 Universidade Federal de Santa Maria Centro de Ciências da Saúde Programa de Pós-Graduação em Farmacologia
    [Show full text]
  • Phcogj.Com Potential Activity of Medicinal Plants As Pain Modulators
    Pharmacogn J. 2021; 13(1): 248-263 A Multifaceted Journal in the field of Natural Products and Pharmacognosy Review Article www.phcogj.com Potential Activity of Medicinal Plants as Pain Modulators: A Review Carmen R. Silva-Correa1,*, Jorge L. Campos-Reyna2, Víctor E Villarreal-La Torre1, Abhel A. Calderón-Peña3, María V. González Blas1, Cinthya L. Aspajo-Villalaz3, José L. Cruzado-Razco1, William Antonio Sagástegui- Guarniz1, Luz M. Guerrero-Espino2, Julio Hilario-Vargas2 ABSTRACT This review aims to demonstrate the relevance that medicinal plants and their promising results have in prevention and treatment of pain. The neurophysiological bases of pain have been analyzed and the potential mechanisms of action have been proposed, it has also been Carmen R. Silva-Correa1,*, determined that the main experimental models used for the evaluation of the analgesic Jorge L. Campos-Reyna2, Víctor potential are: acetic acid-induced writhing test, formalin test, hot-plate test, capsaicin-induced E Villarreal-La Torre1, Abhel nociception, cinnamaldehyde-induced nociception, glutamate-induced nociception, tail–flick A. Calderón-Peña3, María V. test and tail immersion test. There are countless medicinal plants with potential analgesic González Blas1, Cinthya L. Aspajo- activity, in some of them main responsible compounds for the activity are flavonoids (vitexin, Villalaz3, José L. Cruzado-Razco1, quercetin, naringenin, astragalin, eupatilin), alkaloids (scotanamine B, bullatine A, S-(+)- William Antonio Sagástegui- dicentrine, stephalagine, lappaconitine), terpenoids (p-cymene, thymol, menthol, citronellol, Guarniz1, Luz M. Guerrero- myrcene, carvacrol, linalool) and saponins (siolmatroside I, cayaponoside D, cayaponoside B4, Espino2, Julio Hilario-Vargas2 cayaponoside A1); however, all studies have only been carried out up to pre-clinical stages.
    [Show full text]
  • RSC Advances
    RSC Advances View Article Online REVIEW View Journal | View Issue A review on potential of natural products in the management of COVID-19 Cite this: RSC Adv.,2021,11,16711 Rudra Chakravarti,†a Rajveer Singh,†a Arijit Ghosh,†b Dhritiman Dey,a Priyanka Sharma,a Ravichandiran Velayutham,a Syamal Roy*c and Dipanjan Ghosh *a At the end of 2019, a life threatening viral infection (COVID-19) caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported. This virus has spread worldwide in a short duration and forced the world to face unprecedented life and economic loss. To date, there are no known specific drugs to combat this virus and the process for new drug development is lengthy. Most promising candidates, which emerged as potential leads, were abandoned in the later phases of clinical trials. Repurposing of already approved drugs for other therapeutic applications can be done only after extensive testing for safety and efficacy. With no definite therapeutics in the horizon, natural products are in extensive use arbitrarily as anti-viral Creative Commons Attribution-NonCommercial 3.0 Unported Licence. agents and immune boosters. For ages it has been known that most natural products possess potent anti-viral activity and it is no different for SARS-CoV-2. It has been shown that natural products display inhibitory effects on MERS-CoV and SARS-CoV infections. In silico studies have shown that various natural products have strong binding affinity for and inhibitory action on the non-structural proteins of the virus, namely PLPRO,MPRO, and RdRp, and structural proteins such as Received 25th January 2021 spike (S) protein.
    [Show full text]